表紙：変形性関節症の世界市場 - 市場シェア・規模・動向・業界分析：治療タイプ別、疾患タイプ別、流通チャネル別、投与経路別、地域別、セグメント予測（2022年～2030年）

市場調査レポート

商品コード

1150067

変形性関節症の世界市場 - 市場シェア・規模・動向・業界分析：治療タイプ別、疾患タイプ別、流通チャネル別、投与経路別、地域別、セグメント予測（2022年～2030年）

Osteoarthritis Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drugs, Assistive Devices); By Disease Type; By Distribution Channel; By Route of Administration; By Region; Segment Forecast, 2022 - 2030

出版日: 2022年10月01日 | 発行: Polaris Market Research

| ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,250 668,780円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 826,140円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 983,500円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.36円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の変形性関節症の市場規模は、2030年までに153億米ドルに達すると予測されています。

当レポートでは、世界の変形性関節症市場を調査しており、市場の概要、市場規模や予測、動向、促進要因・抑制要因、治療タイプ別・疾患タイプ別・流通チャネル別・投与経路別・地域別などの分析、さらに企業プロファイルなどを提供しています。

変形性関節症 - 業界のスナップショット
変形性関節症市場力学
- 促進要因と機会
- 抑制要因と課題
ポーターのファイブフォース分析
- 供給企業の交渉力
- 新規参入者の脅威
- 買い手の交渉力
- 代替品の脅威
- 既存企業間の競争力
PESTLE分析
変形性関節症業界の動向
バリューチェーン分析
COVID-19影響分析

第5章世界の変形性関節症市場：治療タイプ別

主な調査結果
イントロダクション
- 世界の変形性関節症市場、治療タイプ別（2018年～2030年）
薬剤
- 世界の変形性関節症市場、薬剤別、地域別（2018年～2030年）
- 関節内補充薬
- 非ステロイド性抗炎症薬
- 鎮痛剤
- コルチコステロイド
補助装置
- 世界の変形性関節症市場、補助装置別、地域別（2018年～2030年）

第6章世界の変形性関節症市場：流通チャネル別

主な調査結果
イントロダクション
- 世界の変形性関節症市場、流通チャネル別（2018年～2030年）
病院薬局
- 世界の変形性関節症市場、病院薬局別、地域別（2018年～2030年）
小売薬局
- 世界の変形性関節症市場、小売薬局別、地域別（2018年～2030年）
ドラッグストア
- 世界の変形性関節症市場、ドラッグストア別、地域別（2018年～2030年）
eコマース
- 世界の変形性関節症市場、eコマース別、地域別（2018年～2030年）

第7章世界の変形性関節症市場：疾患タイプ別

主な調査結果
イントロダクション
- 世界の変形性関節症市場、疾患タイプ別（2018年～2030年）
膝の変形性関節症
- 世界の変形性関節症市場、膝の変形性関節症別、地域別（2018年～2030年）
脊椎の変形性関節症
- 世界の変形性関節症市場、脊椎の変形性関節症別、地域別（2018年～2030年）
足・足首の変形性関節症
- 世界の変形性関節症市場、足・足首の変形性関節症別、地域別（2018年～2030年）
肩の変形性関節症
- 世界の変形性関節症市場、肩の変形性関節症別、地域別（2018年～2030年）
手の変形性関節症
- 世界の変形性関節症市場、手の変形性関節症別、地域別（2018年～2030年）

第8章世界の変形性関節症市場：投与経路別

主な調査結果
イントロダクション
- 世界の変形性関節症市場、投与経路別（2018年～2030年）
非経口経路
- 世界の変形性関節症市場、非経口経路別、地域別（2018年～2030年）
局所経路
- 世界の変形性関節症市場、局所経路別、地域別（2018年～2030年）
経口経路
- 世界の変形性関節症市場、経口経路別、地域別（2018年～2030年）

第9章世界の変形性関節症市場：地域別

主な調査結果
イントロダクション
- 変形性関節症市場の評価、地域別（2018年～2030年）
変形性関節症市場 - 北米
- 北米：変形性関節症市場、治療タイプ別（2018年～2030年）
- 北米：変形性関節症市場、投与経路別（2018年～2030年）
- 北米：変形性関節症市場、流通チャネル別（2018年～2030年）
- 北米：変形性関節症市場、疾患タイプ別（2018年～2030年）
- 変形性関節症市場 - 米国
- 変形性関節症市場 - カナダ
変形性関節症市場 - 欧州
- 欧州：変形性関節症市場、治療タイプ別（2018年～2030年）
- 欧州：変形性関節症市場、投与経路別（2018年～2030年）
- 欧州：変形性関節症市場、流通チャネル別（2018年～2030年）
- 欧州：変形性関節症市場、疾患タイプ別（2018年～2030年）
- 変形性関節症市場 - 英国
- 変形性関節症市場 - フランス
- 変形性関節症市場 - ドイツ
- 変形性関節症市場 - イタリア
- 変形性関節症市場 - スペイン
- 変形性関節症市場 - オランダ
- 変形性関節症市場 - ロシア
変形性関節症市場 - アジア太平洋
- アジア太平洋：変形性関節症市場、治療タイプ別（2018年～2030年）
- アジア太平洋：変形性関節症市場、投与経路別（2018年～2030年）
- アジア太平洋：変形性関節症市場、流通チャネル別（2018年～2030年）
- アジア太平洋：変形性関節症市場、疾患タイプ別（2018年～2030年）
- 変形性関節症市場 - 中国
- 変形性関節症市場 - インド
- 変形性関節症市場 - 日本
- 変形性関節症市場 - マレーシア
- 変形性関節症市場 - インドネシア
- 変形性関節症市場 - 韓国
変形性関節症市場 - 中東・アフリカ
- 中東・アフリカ：変形性関節症市場、治療タイプ別（2018年～2030年）
- 中東・アフリカ：変形性関節症市場、投与経路別（2018年～2030年）
- 中東・アフリカ：変形性関節症市場、流通チャネル別（2018年～2030年）
- 中東・アフリカ：変形性関節症市場、疾患タイプ別（2018年～2030年）
- 変形性関節症市場 - サウジアラビア
- 変形性関節症市場 - 南アフリカ
- 変形性関節症市場 - イスラエル
- 変形性関節症市場 - アラブ首長国連邦
変形性関節症市場 - ラテンアメリカ
- ラテンアメリカ：変形性関節症市場、治療タイプ別（2018年～2030年）
- ラテンアメリカ：変形性関節症市場、投与経路別（2018年～2030年）
- ラテンアメリカ：変形性関節症市場、流通チャネル別（2018年～2030年）
- ラテンアメリカ：変形性関節症市場、疾患タイプ別（2018年～2030年）
- 変形性関節症市場 - メキシコ
- 変形性関節症市場 - ブラジル
- 変形性関節症市場 - アルゼンチン

第10章競合情勢

拡大・買収の分析
- 拡大
- 買収
パートナーシップ/コラボレーション/協定/公開

第11章企業プロファイル

ABIOGEN PHARMA S.p.A
Assertio Therapeutics, Inc
Abbott Laboratories Incorporation
Apotex Inc
Ampio Pharmaceuticals Inc
Bayer AG
Eli Lilly and Company
Horizon Therapeutics plc
Johnson & Johnson
Merck Sharp & Dohme Corp
Mylan N.V
Novartis AG
Pfizer Inc
Reckitt Benckiser Group PLC
Sanofi SA
Tolmar Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Zimmer Biomet Holding

図表

List of Tables

Table 1 Global Osteoarthritis Market, by Treatment Type, by Region, 2018 - 2030 (USD Billion)
Table 2 Global Osteoarthritis Market, by Distribution Channel, by Region, 2018 - 2030 (USD Billion)
Table 3 Global Osteoarthritis Market, by Disease Type, by Region, 2018 - 2030 (USD Billion)
Table 4 Global Osteoarthritis Market, by Route of Administration, by Region, 2018 - 2030 (USD Billion)
Table 5 Osteoarthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Table 6 North America: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 7 North America: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 8 North America: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 9 North America: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 10 U.S.: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 11 U.S.: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 12 U.S.: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 13 U.S.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 14 Canada: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 15 Canada: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 16 Canada: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 17 Canada: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 18 Europe: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 19 Europe: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 20 Europe: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 21 Europe: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 22 Germany: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 23 Germany: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 24 Germany: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 25 Germany: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 26 France: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 27 France: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 28 France: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 29 France: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 30 UK: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 31 UK: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 32 UK: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 33 UK: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 34 Italy: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 35 Italy: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 36 Italy: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 37 Italy: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 38 Netherlands: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 39 Netherlands: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 40 Netherlands: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 41 Netherlands: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 42 Spain: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 43 Spain: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 44 Spain: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 45 Spain: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 46 Russia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 47 Russia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 48 Russia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 49 Russia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 50 Asia Pacific: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 51 Asia Pacific: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 52 Asia Pacific: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 53 Asia Pacific: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 54 China: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 55 China: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 56 China: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 57 China: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 58 Japan: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 59 Japan: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 60 Japan: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 61 Japan: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 62 India: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 63 India: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 64 India: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 65 India: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 66 Indonesia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 67 Indonesia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 68 Indonesia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 69 Indonesia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 70 Malaysia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 71 Malaysia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 72 Malaysia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 73 Malaysia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 74 South Korea: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 75 South Korea: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 76 South Korea: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 77 South Korea: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 78 Latin America: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 79 Latin America: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 80 Latin America: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 81 Latin America: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 82 Brazil: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 83 Brazil: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 84 Brazil: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 85 Brazil: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 86 Mexico: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 87 Mexico: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 88 Mexico: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 89 Mexico: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 90 Argentina: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 91 Argentina: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 92 Argentina: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 93 Argentina: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 94 Middle East & Africa: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 95 Middle East & Africa: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 96 Middle East & Africa: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 97 Middle East & Africa: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 98 UAE: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 99 UAE: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 100 UAE: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 101 UAE: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 102 Saudi Arabia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 103 Saudi Arabia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 104 Saudi Arabia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 105 Saudi Arabia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 106 South Africa: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 107 South Africa: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 108 South Africa: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 109 South Africa: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 110 Israel: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
Table 111 Israel: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
Table 112 Israel: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
Table 113 Israel: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Osteoarthritis Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Route of Administration

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Treatment Type

Figure 7. Global Osteoarthritis Market, by Treatment Type, 2021 & 2030 (USD Billion)

Figure 8. Market by Route of Administration

Figure 9. Global Osteoarthritis Market, by Route of Administration, 2021 & 2030 (USD Billion)

Figure 10. Market by Distribution Channel

Figure 11. Global Osteoarthritis Market, by Distribution Channel, 2021 & 2030 (USD Billion)

Figure 12. Market by Disease Type

Figure 13. Global Osteoarthritis Market, by Disease Type, 2021 & 2030 (USD Billion)

Figure 14. Osteoarthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Osteoarthritis Market

Product Code: PM1348

The global osteoarthritis market size is expected to reach USD 15.30 billion by 2030, according to a new study by Polaris Market Research. The report "Osteoarthritis Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drugs, Assistive Devices); By Disease Type; By Distribution Channel; By Route of Administration; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising senior population and the rising prevalence of osteoarthritis are the main drivers of the market. For instance, as per the Centers for Disease Control and Prevention (CDC), 54.4 million US people, or one in four, have some type of arthritis, and by 2040, that number is expected to rise to 78 million.

Although there are more than 100 different kinds of arthritis, osteoarthritis (OA), which affects 32.5 million US adults, is the most widespread variety. 88% of those with OA are 45 years of age or older, and 43% are 65 years of age or older. There are significant societal and individual costs associated with the high frequency of arthritis.

Additionally, there have been technological developments, and improvements in diagnostics, are the factors boosting the market growth over the forecast period. Knee kinesiography, an advanced medical tool, is transforming how doctors treat osteoarthritis of the knee. As stated by the Public Health Agency of Canada, this type of osteoarthritis affects about four million Canadians or 13.6% of the community. When compared to males (11.1% and 7.5 per 1,000 persons per year), women(16.1% and 10.0 per 1,000 persons per year, respectively) have a greater frequency and prevalence of osteoarthritis diagnoses.

Further, in January 2022, TrialSpark announced the establishment of High Line Bio after acquiring from Merck KGaA the global license to sprifermin. Sprifermin is a technologically advanced disease-modifying recombinant version of human fibroblast development factor 18 that is being investigated as potential osteoarthritis (OA) treatment by encouraging cartilage formation.

One of the most unmet medical requirements among musculoskeletal disorders, OA is a degenerative joint disease that occurs partially due to cartilage loss. Thus, the rising prevalence of OA among the senior population and the development of technologically advanced treatments for OA are the factors boosting the market growth over the forecast period.

Additionally, the desire for minimally invasive surgical methods, greater public awareness, better treatment alternatives, and patient willingness to pursue therapy are all anticipated to support the expansion of the market.

Osteoarthritis Market Report Highlights

Knee osteoarthritis segment is anticipated to grow at a significant CAGR over the forecast period due to the high occurrence of knee osteoarthritis across the globe

Parental route segment accounted for the highest revenue share. This can be ascribed to the widespread use of the parenteral route for giving osteoarthritis treatments because of its simplicity, improved pharmacokinetics, and improved pharmacodynamics, which lead to higher patient compliance.

Asia Pacific is expected to grow at a fastest CAGR over the projected period on account of a rise in osteoarthritis incidence, a growth in the number of women, an expansion in health care spending, and a lack of physical activity

The global market includes Apotex Inc., Ampio Pharmaceuticals Inc., Bayer AG, Flexion Therapeutics, Inc., GlaxoSmithKline PLC, Horizon Therapeutics plc, Reckitt Benckiser Group PLC, Sanofi SA, Tolmar Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., and Zimmer Biomet Holding

Polaris Market Research has segmented the osteoarthritis market report based on treatment type, disease type, distribution channel, route of administration, and region:

Osteoarthritis, Treatment Type Outlook (Revenue - USD Billion, 2018 - 2030)

Drugs

Viscosupplementation Agents

Nonsteroidal Anti-inflammatory Drugs

Naproxen

Aspirin

Diclofenac

Ibuprofen

Other NSAIDs

Analgesics

Duloxetine

Acetaminophen

Corticosteroids

Assistive Devices

Osteoarthritis, Disease Type Outlook (Revenue - USD Billion, 2018 - 2030)

Knee Osteoarthritis

Spine Osteoarthritis

Foot & Ankle Osteoarthritis

Shoulder Osteoarthritis

Hand Osteoarthritis

Osteoarthritis, Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)

Hospital Pharmacies

Retail Pharmacies

Drug Stores

E-Commerce

Osteoarthritis, Route of Administration Outlook (Revenue - USD Billion, 2018 - 2030)

Parenteral Route

Topical Route

Oral Route

Osteoarthritis, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Osteoarthritis Market Insights

4.1. Osteoarthritis - Industry Snapshot
4.2. Osteoarthritis Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing prevalence of osteoarthritis
  - 4.2.1.2. Growing population susceptible to osteoarthritis
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Commercialization of alternatives
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Osteoarthritis Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Osteoarthritis Market, by Treatment Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
5.3. Drugs
- 5.3.1. Global Osteoarthritis Market, by Drugs, by Region, 2018 - 2030 (USD Billion)
- 5.3.2. Viscosupplementation Agents
  - 5.3.2.1. Global Osteoarthritis Market, by Viscosupplementation Agents, by Region, 2018 - 2030 (USD Billion)
- 5.3.3. Nonsteroidal Anti-inflammatory Drugs
  - 5.3.3.1. Global Osteoarthritis Market, by Nonsteroidal Anti-inflammatory Drugs, by Region, 2018 - 2030 (USD Billion)
  - 5.3.3.2. Naproxen
  - 5.3.3.2.1. Global Osteoarthritis Market, by Naproxen, by Region, 2018 - 2030 (USD Billion)
  - 5.3.3.3. Aspirin
  - 5.3.3.3.1. Global Osteoarthritis Market, by Aspirin, by Region, 2018 - 2030 (USD Billion)
  - 5.3.3.4. Diclofenac
  - 5.3.3.4.1. Global Osteoarthritis Market, by Diclofenac, by Region, 2018 - 2030 (USD Billion)
  - 5.3.3.5. Ibuprofen
  - 5.3.3.5.1. Global Osteoarthritis Market, by Ibuprofen, by Region, 2018 - 2030 (USD Billion)
  - 5.3.3.6. Other NSAIDs
  - 5.3.3.6.1. Global Osteoarthritis Market, by Other NSAIDs, by Region, 2018 - 2030 (USD Billion)
- 5.3.4. Analgesics
  - 5.3.4.1. Global Osteoarthritis Market, by Analgesics, by Region, 2018 - 2030 (USD Billion)
  - 5.3.4.2. Duloxetine
  - 5.3.4.2.1. Global Osteoarthritis Market, by Duloxetine, by Region, 2018 - 2030 (USD Billion)
  - 5.3.4.3. Acetaminophen
  - 5.3.4.3.1. Global Osteoarthritis Market, by Acetaminophen, by Region, 2018 - 2030 (USD Billion)
- 5.3.5. Corticosteroids
  - 5.3.5.1. Global Osteoarthritis Market, by Corticosteroids, by Region, 2018 - 2030 (USD Billion)
5.4. Assistive Devices
- 5.4.1. Global Osteoarthritis Market, by Assistive Devices, by Region, 2018 - 2030 (USD Billion)

6. Global Osteoarthritis Market, by Distribution Channel

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
6.3. Hospital Pharmacies
- 6.3.1. Global Osteoarthritis Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Billion)
6.4. Retail Pharmacies
- 6.4.1. Global Osteoarthritis Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Billion)
6.5. Drug Stores
- 6.5.1. Global Osteoarthritis Market, by Drug Stores, by Region, 2018 - 2030 (USD Billion)
6.6. E-Commerce
- 6.6.1. Global Osteoarthritis Market, by E-Commerce, by Region, 2018 - 2030 (USD Billion)

7. Global Osteoarthritis Market, by Disease Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
7.3. Knee Osteoarthritis
- 7.3.1. Global Osteoarthritis Market, by Knee Osteoarthritis, by Region, 2018 - 2030 (USD Billion)
7.4. Spine Osteoarthritis
- 7.4.1. Global Osteoarthritis Market, by Spine Osteoarthritis, by Region, 2018 - 2030 (USD Billion)
7.5. Foot & Ankle Osteoarthritis
- 7.5.1. Global Osteoarthritis Market, by Foot & Ankle Osteoarthritis, by Region, 2018 - 2030 (USD Billion)
7.6. Shoulder Osteoarthritis
- 7.6.1. Global Osteoarthritis Market, by Shoulder Osteoarthritis, by Region, 2018 - 2030 (USD Billion)
7.7. Hand Osteoarthritis
- 7.7.1. Global Osteoarthritis Market, by Hand Osteoarthritis, by Region, 2018 - 2030 (USD Billion)

8. Global Osteoarthritis Market, by Route of Administration

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
8.3. Parenteral Route
- 8.3.1. Global Osteoarthritis Market, by Parenteral Route, by Region, 2018 - 2030 (USD Billion)
8.4. Topical Route
- 8.4.1. Global Osteoarthritis Market, by Topical Route, by Region, 2018 - 2030 (USD Billion)
8.5. Oral Route
- 8.5.1. Global Osteoarthritis Market, by Oral Route, by Region, 2018 - 2030 (USD Billion)

9. Global Osteoarthritis Market, by Geography

9.1. Key findings
9.2. Introduction
- 9.2.1. Osteoarthritis Market Assessment, By Geography, 2018 - 2030 (USD Billion)
9.3. Osteoarthritis Market - North America
- 9.3.1. North America: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.3.5. Osteoarthritis Market - U.S.
  - 9.3.5.1. U.S.: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.3.5.2. U.S.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.3.5.3. U.S.: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.3.5.4. U.S.: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.3.6. Osteoarthritis Market - Canada
  - 9.3.6.1. Canada: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.3.6.2. Canada: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.3.6.3. Canada: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.3.6.4. Canada: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
9.4. Osteoarthritis Market - Europe
- 9.4.1. Europe: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.5. Osteoarthritis Market - UK
  - 9.4.5.1. UK: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.4.5.2. UK: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.4.5.3. UK: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.4.5.4. UK: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.6. Osteoarthritis Market - France
  - 9.4.6.1. France: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.4.6.2. France: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.4.6.3. France: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.4.6.4. France: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.7. Osteoarthritis Market - Germany
  - 9.4.7.1. Germany: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.4.7.2. Germany: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.4.7.3. Germany: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.4.7.4. Germany: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.8. Osteoarthritis Market - Italy
  - 9.4.8.1. Italy: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.4.8.2. Italy: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.4.8.3. Italy: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.4.8.4. Italy: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.9. Osteoarthritis Market - Spain
  - 9.4.9.1. Spain: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.4.9.2. Spain: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.4.9.3. Spain: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.4.9.4. Spain: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.10. Osteoarthritis Market - Netherlands
  - 9.4.10.1. Netherlands: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.4.10.2. Netherlands: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.4.10.3. Netherlands: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.4.10.4. Netherlands: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.4.11. Osteoarthritis Market - Russia
  - 9.4.11.1. Russia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.4.11.2. Russia.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.4.11.3. Russia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.4.11.4. Russia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
9.5. Osteoarthritis Market - Asia Pacific
- 9.5.1. Asia Pacific: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.5. Osteoarthritis Market - China
  - 9.5.5.1. China: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.5.5.2. China.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.5.5.3. China: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.5.5.4. China: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.6. Osteoarthritis Market - India
  - 9.5.6.1. India: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.5.6.2. India.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.5.6.3. India: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.5.6.4. India: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.7. Osteoarthritis Market - Japan
  - 9.5.7.1. Japan: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.5.7.2. Japan.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.5.7.3. Japan: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.5.7.4. Japan: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.8. Osteoarthritis Market - Malaysia
  - 9.5.8.1. Malaysia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.5.8.2. Malaysia.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.5.8.3. Malaysia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.5.8.4. Malaysia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.9. Osteoarthritis Market - Indonesia
  - 9.5.9.1. Indonesia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.5.9.2. Indonesia.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.5.9.3. Indonesia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.5.9.4. Indonesia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.5.10. Osteoarthritis Market - South Korea
  - 9.5.10.1. South Korea: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.5.10.2. South Korea.: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.5.10.3. South Korea: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.5.10.4. South Korea: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
9.6. Osteoarthritis Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.5. Osteoarthritis Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.6. Osteoarthritis Market - South Africa
  - 9.6.6.1. South Africa: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.6.6.2. South Africa: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.6.6.3. South Africa: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.6.6.4. South Africa: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.7. Osteoarthritis Market - Israel
  - 9.6.7.1. Israel: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.6.7.2. Israel: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.6.7.3. Israel: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.6.7.4. Israel: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.6.8. Osteoarthritis Market - UAE
  - 9.6.8.1. UAE: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.6.8.2. UAE: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.6.8.3. UAE: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.6.8.4. UAE: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
9.7. Osteoarthritis Market - Latin America
- 9.7.1. Latin America: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.7.5. Osteoarthritis Market - Mexico
  - 9.7.5.1. Mexico: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.7.5.2. Mexico: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.7.5.3. Mexico: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.7.5.4. Mexico: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.7.6. Osteoarthritis Market - Brazil
  - 9.7.6.1. Brazil: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.7.6.2. Brazil: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.7.6.3. Brazil: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.7.6.4. Brazil: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)
- 9.7.7. Osteoarthritis Market - Argentina
  - 9.7.7.1. Argentina: Osteoarthritis Market, by Treatment Type, 2018 - 2030 (USD Billion)
  - 9.7.7.2. Argentina: Osteoarthritis Market, by Route of Administration, 2018 - 2030 (USD Billion)
  - 9.7.7.3. Argentina: Osteoarthritis Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  - 9.7.7.4. Argentina: Osteoarthritis Market, by Disease Type, 2018 - 2030 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. ABIOGEN PHARMA S.p.A
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Assertio Therapeutics, Inc
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Abbott Laboratories Incorporation
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Apotex Inc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Ampio Pharmaceuticals Inc
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Bayer AG
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Eli Lilly and Company
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Horizon Therapeutics plc
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Johnson & Johnson
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Merck Sharp & Dohme Corp
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Mylan N.V
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Novartis AG
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Pfizer Inc
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Reckitt Benckiser Group PLC
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Sanofi SA
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
11.16. Tolmar Pharmaceuticals, Inc
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
11.17. Teva Pharmaceutical Industries Ltd
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
11.18. Zimmer Biomet Holding
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development

変形性関節症の世界市場 - 市場シェア・規模・動向・業界分析：治療タイプ別、疾患タイプ別、流通チャネル別、投与経路別、地域別、セグメント予測（2022年～2030年）

Osteoarthritis Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drugs, Assistive Devices); By Disease Type; By Distribution Channel; By Route of Administration; By Region; Segment Forecast, 2022 - 2030

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の変形性関節症市場の洞察

第5章世界の変形性関節症市場：治療タイプ別

第6章世界の変形性関節症市場：流通チャネル別

第7章世界の変形性関節症市場：疾患タイプ別

第8章世界の変形性関節症市場：投与経路別

第9章世界の変形性関節症市場：地域別

第10章競合情勢

第11章企業プロファイル

List of Tables

List of Figures

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Osteoarthritis Market Insights

5. Global Osteoarthritis Market, by Treatment Type

6. Global Osteoarthritis Market, by Distribution Channel

7. Global Osteoarthritis Market, by Disease Type

8. Global Osteoarthritis Market, by Route of Administration

9. Global Osteoarthritis Market, by Geography

10. Competitive Landscape

11. Company Profiles

変形性関節症の世界市場 - 市場シェア・規模・動向・業界分析：治療タイプ別、疾患タイプ別、流通チャネル別、投与経路別、地域別、セグメント予測（2022年～2030年）

Osteoarthritis Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drugs, Assistive Devices); By Disease Type; By Distribution Channel; By Route of Administration; By Region; Segment Forecast, 2022 - 2030

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の変形性関節症市場の洞察

第5章 世界の変形性関節症市場：治療タイプ別

第6章 世界の変形性関節症市場：流通チャネル別

第7章 世界の変形性関節症市場：疾患タイプ別

第8章 世界の変形性関節症市場：投与経路別

第9章 世界の変形性関節症市場：地域別

第10章 競合情勢

第11章 企業プロファイル

List of Tables

List of Figures

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Osteoarthritis Market Insights

5. Global Osteoarthritis Market, by Treatment Type

6. Global Osteoarthritis Market, by Distribution Channel

7. Global Osteoarthritis Market, by Disease Type

8. Global Osteoarthritis Market, by Route of Administration

9. Global Osteoarthritis Market, by Geography

10. Competitive Landscape

11. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の変形性関節症市場の洞察

第5章世界の変形性関節症市場：治療タイプ別

第6章世界の変形性関節症市場：流通チャネル別

第7章世界の変形性関節症市場：疾患タイプ別

第8章世界の変形性関節症市場：投与経路別

第9章世界の変形性関節症市場：地域別

第10章競合情勢

第11章企業プロファイル